OMNIVIUM
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Dec 2025)
What this means for you
This application is over — abandoned 22 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90839914
- Mark type
- Stylized text
- Filed
- 21 Jul 2021
- Published for opposition
- 27 Sept 2022
- Abandoned
- 22 Dec 2025
- Attorney of record
- Michael C. Cannata
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for curing, halting and preventing cardiovascular, bacterial, viral, psychiatric, eye, central nervous system, gastrointestinal, and cancer related diseases, easing symptoms, or helping in the diagnosis of illnesses; house mark for a full line of pharmaceuticals
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; pharmaceutical research and development; medical research; scientific research; scientific research and development
Owner
- Omnivium Pharmaceuticals LLC, Rahway, NJ, US
- Omnivium Pharmaceuticals LLC, Rahway, NJ, US
Prosecution history
- 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2025 — SOU EXTENSION 5 GRANTED
- 11 May 2025 — SOU EXTENSION 5 FILED
- 29 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2024 — SOU EXTENSION 4 GRANTED
- 18 Nov 2024 — SOU EXTENSION 4 FILED
- 18 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 21 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2024 — SOU EXTENSION 3 GRANTED
- 20 May 2024 — SOU EXTENSION 3 FILED
- 20 May 2024 — SOU TEAS EXTENSION RECEIVED